StemCell Therapy

The New Jersey Institute of Technology will collaborate with the New Jersey Innovation Institute, an NJIT corporation, to offer a professional science masters degree program and professional graduate certificate in the rapidly expanding field of cell and gene therapy.

Students be able to begin taking the 30-credit masters degree in spring 2020 as part of NJITs Department of Chemistry and Environmental Sciences pharmaceutical chemistry masters program.

NJIT says this is a four-course certificate program for anyone who is seeking training in cutting-edge technologies required for processing and commercializing of new therapies.

Hands-on training in the fields newest approaches and technologies will be supported at NJITs labs and at The New Jersey Innovation Institutes Cell and Gene Therapy Development Center. NJII says the center will upgrade the knowledge and skills of bio-pharmaceutical professionals in the processing of new, breakthrough classes of biologic therapies.

Both programs were developed to meet growing demands from the bio-pharmaceutical industry for trained scientists and engineers at the forefront of the coming wave of breakthrough gene and cell therapies, including advanced gene delivery technologies to immunotherapies such as CAR-T cancer therapy.

Original post:
NJIT to start programs in cell and gene therapy - NJBIZ

This entry was posted on December 25, 2019 at 8:48 am and is filed under Gene therapy. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |